Fuller & Thaler Asset Management Inc. Buys Shares of 10,625 GE HealthCare Technologies Inc. $GEHC

Key Points

• Fuller & Thaler Asset Management Inc. invested approximately $858,000 in GE HealthCare Technologies by purchasing 10,625 shares during the 1st quarter.
• GE HealthCare Technologies recently reported $1.06 earnings per share for the last quarter, surpassing analysts' expectations of $0.91.
• The company has launched a $1 billion share repurchase program, indicating the board's belief that its stock is currently undervalued.

Fuller & Thaler Asset Management Inc. purchased a new stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 10,625 shares of the company's stock, valued at approximately $858,000.

Several other large investors also recently made changes to their positions in the company. LGT Financial Advisors LLC increased its stake in shares of GE HealthCare Technologies by 46.2% during the fourth quarter. LGT Financial Advisors LLC now owns 389 shares of the company's stock valued at $30,000 after acquiring an additional 123 shares during the period. Integrated Wealth Concepts LLC increased its stake in shares of GE HealthCare Technologies by 0.7% during the fourth quarter. Integrated Wealth Concepts LLC now owns 17,173 shares of the company's stock valued at $1,343,000 after acquiring an additional 126 shares during the period. Knuff & Co LLC increased its stake in shares of GE HealthCare Technologies by 1.5% during the first quarter. Knuff & Co LLC now owns 10,276 shares of the company's stock valued at $829,000 after acquiring an additional 150 shares during the period. Graypoint LLC increased its stake in shares of GE HealthCare Technologies by 5.7% during the first quarter. Graypoint LLC now owns 3,028 shares of the company's stock valued at $244,000 after acquiring an additional 162 shares during the period. Finally, Ferguson Wellman Capital Management Inc. increased its stake in shares of GE HealthCare Technologies by 3.2% during the first quarter. Ferguson Wellman Capital Management Inc. now owns 5,336 shares of the company's stock valued at $431,000 after acquiring an additional 166 shares during the period. Institutional investors and hedge funds own 82.06% of the company's stock.

GE HealthCare Technologies Trading Down 0.7%

GE HealthCare Technologies stock traded down $0.49 during midday trading on Tuesday, reaching $74.10. The stock had a trading volume of 391,401 shares, compared to its average volume of 3,993,773. The firm's fifty day simple moving average is $74.04 and its two-hundred day simple moving average is $74.95. GE HealthCare Technologies Inc. has a twelve month low of $57.65 and a twelve month high of $94.80. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.16 and a quick ratio of 0.93. The firm has a market cap of $33.83 billion, a price-to-earnings ratio of 15.16, a PEG ratio of 2.87 and a beta of 1.13.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last posted its quarterly earnings data on Wednesday, July 30th. The company reported $1.06 EPS for the quarter, topping analysts' consensus estimates of $0.91 by $0.15. GE HealthCare Technologies had a net margin of 11.22% and a return on equity of 23.93%. The firm had revenue of $5 billion during the quarter, compared to analyst estimates of $4.96 billion. During the same quarter last year, the business posted $1.00 EPS. The company's revenue was up 3.5% on a year-over-year basis. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. Equities analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies declared that its board has approved a share repurchase program on Wednesday, April 30th that permits the company to repurchase $1.00 billion in shares. This repurchase authorization permits the company to reacquire up to 3.1% of its shares through open market purchases. Shares repurchase programs are generally a sign that the company's board believes its stock is undervalued.

GE HealthCare Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Friday, July 25th were paid a $0.035 dividend. The ex-dividend date of this dividend was Friday, July 25th. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. GE HealthCare Technologies's dividend payout ratio (DPR) is currently 2.87%.

Wall Street Analysts Forecast Growth

A number of research analysts recently commented on the stock. The Goldman Sachs Group lowered their price objective on shares of GE HealthCare Technologies from $94.00 to $82.00 and set a "buy" rating on the stock in a research note on Thursday, May 1st. BTIG Research reiterated a "buy" rating on shares of GE HealthCare Technologies in a research note on Monday, July 14th. Morgan Stanley reduced their target price on shares of GE HealthCare Technologies from $78.00 to $74.00 and set an "equal weight" rating for the company in a report on Thursday, July 31st. Wall Street Zen upgraded shares of GE HealthCare Technologies from a "hold" rating to a "buy" rating in a report on Saturday, May 31st. Finally, Evercore ISI reduced their target price on shares of GE HealthCare Technologies from $96.00 to $85.00 and set an "outperform" rating for the company in a report on Thursday, May 1st. Eight equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat.com, GE HealthCare Technologies presently has a consensus rating of "Moderate Buy" and a consensus price target of $88.55.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.